tert-Butyl 4-bromo-3-(trifluoromethyl)benzoate

Catalog No.: 
ACKKPB569
CAS No.: 
1540336-32-0
Molecular Formula: 
C12H12BrF3O2
Molecular Weight: 
325.12
tert-Butyl 4-bromo-3-(trifluoromethyl)benzoate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg98%$109.00InquiryInquiry
100mg98%$155.00InquiryInquiry
250mg98%$214.00InquiryInquiry
1g98%$517.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 4-bromo-3-(trifluoromethyl)benzoate
IUPAC Nametert-butyl 4-bromo-3-(trifluoromethyl)benzoate
MDL No.MFCD25648459
Molecular FormulaC12H12BrF3O2
Molecular Weight325.12
SMILESO=C(OC(C)(C)C)C1=CC=C(Br)C(C(F)(F)F)=C1
InChI KeyWETORNGZFRIBPL-UHFFFAOYSA-N
Synonymtert-Butyl 4-bromo-3-(trifluoromethyl)benzoate;Benzoic acid, 4-bromo-3-(trifluoromethyl)-, 1,1-dimethylethyl ester
CAS No.1540336-32-0

Synthetic Route by SureRoute

1. ACKKPB569 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACFBPZ072 route compound structure diagram
    ACFBPZ07236809-75-3In Stock
  2. Plus
  3. ACTRXO793 route compound structure diagram
    ACTRXO793914636-26-3In Stock
  4. Then
  5. ACKKPB569 route product structure diagram
    ACKKPB5691540336-32-0
Inquiry

2. ACKKPB569 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACAPQV670 route compound structure diagram
    ACAPQV670161622-14-6In Stock
  4. Then
  5. ACKKPB569 route product structure diagram
    ACKKPB5691540336-32-0
Inquiry

3. ACKKPB569 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACFBPZ072 route compound structure diagram
    ACFBPZ07236809-75-3In Stock
  2. Plus
  3. ACAPQV670 route compound structure diagram
    ACAPQV670161622-14-6In Stock
  4. Then
  5. ACKKPB569 route product structure diagram
    ACKKPB5691540336-32-0
Inquiry

Comments (0)